1246819-64-6
1246819-64-6
Chemical Structure
Levamisole-d5 hydrochloride
Synonym(s): (-)-Tetramisole-d5 hydrochloride
- CAS No.: 1246819-64-6
- Formula:C11H8D5ClN2S
- Molecular Weight:245.78
IUPAC Name: (S)-6-(phenyl-d5)-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole hydrochloride
InChIKey: LAZPBGZRMVRFKY-ISPSRMEYSA-N
SMILES: [2H]C1=C([2H])C([2H])=C([2H])C([2H])=C1[C@@]2([H])CN3C(SCC3)=N2.Cl
Biological Activity: Levamisole-d5 (hydrochloride) is the deuterium labeled Levamisole hydrochloride. Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Levamisole-d5 hydrochloride | 99.99% | Levamisole-d5 (hydrochloride) is the deuterium labeled Levamisole hydrochloride. Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levamisole hydrochloride (Standard) | 99.86% | Levamisole (hydrochloride) (Standard) is the analytical standard of Levamisole (hydrochloride). This product is intended for research and analytical applications. Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Levamisole hydrochloride | 99.94% | Levamisole ((-)-Tetramisole) hydrochloride is an anthelmintic and immunomodulator belonging to a class of synthetic imidazothiazole derivatives. Levamisole hydrochloride has antiviral effects against HSV. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
- [2]. Centers for Disease Control and Prevention (CDC). Agranulocytosis associated with cocaine use - four States, March 2008-November 2009.MMWR Morb Mortal Wkly Rep. 2009 Dec 18;58(49):1381-5. [Content Brief]
